Tobias Hartmann

Tobias Hartmann has a diverse work experience spanning multiple roles and industries. Tobias most recently served as the Director of Product Development at SphingoTec, where they led the development of diagnostic immunoassays and biomarkers for diseases such as acute heart failure, acute kidney injury, obesity, breast cancer, and cardiovascular diseases. Tobias was also responsible for developing companion diagnostics and immunogenicity assays for biotherapeutics. Prior to this role, Tobias held various positions within SphingoTec, including Global Head of Product Development and Head of Laboratory.

Before joining SphingoTec, Tobias worked at 4TEEN4 Pharmaceuticals GmbH as an R&D Scientist. In this role, they contributed to the research and development efforts of the company.

Earlier in their career, Tobias worked as a Research Scientist at Universität Potsdam, where they completed their PhD and conducted postdoctoral research. Tobias also gained research experience through a PhD Internship at Universidade Nova de Lisboa. Overall, Tobias Hartmann's work experience demonstrates their expertise in product development, diagnostics, and research in the fields of biochemistry and biophysics.

Tobias Hartmann's education history begins in 1999 when they attended the Lise-Meitner School of Science and obtained their Allgemeine Hochschulreife (Abitur) degree in 2002. Tobias then continued their education at the same school and completed a Biologisch-technischer Assistent degree from 2002 to 2003. Following that, Tobias attended the University of Potsdam from 2004 to 2010, where they obtained a German Diploma in Biochemistry.

Tobias Hartmann further pursued their academic career at the University of Potsdam, completing their Doctor rerum naturalium degree in Biochemistry and Molecular Biology from 2010 to 2014.

In addition to their formal education, Tobias Hartmann has obtained several certifications. In February 2018, they completed the VITROS 3600 Key Operator Training and the VITROS 3600 Advanced Operator Training at Ortho Clinical Diagnostics. Later in February 2020, Tobias obtained the Good Clinical Practice (GCP) certification from FORUM Institut - Gewerblicher Rechtsschutz. Furthermore, Tobias holds a diploma in "Kinetics and Affinity Analysis with Biacore(TM), Level 1" from GE Healthcare, although the specific month and year of completion are not provided.